HIV infection and the risk of acute myocardial infarction

JAMA Internal Medicine

Volumn 173, Issue 8, 2013, Pages 614-622

  Freiberg, Matthew S ^a,b   Chang, Chung Chou H ^a,b   Kuller, Lewis H ^b   Skanderson, Melissa ^c   Lowy, Elliott ^e,f   Kraemer, Kevin L ^a   Butt, Adeel A ^a   Goetz, Matthew Bidwell ^h,i   Leaf, David ^h,i   Oursler, Kris Ann ^k,l   Rimland, David ⁿ   Barradas, Maria Rodriguez ^o   Brown, Sheldon ^p   Gibert, Cynthia ^q,r   McGinnis, Kathy ^c   Crothers, Kristina ^g   Sico, Jason ^c,d   Crane, Heidi ^g   Warner, Alberta ⁱ   Gottlieb, Stephen ^k   Gottdiener, John ^k   Tracy, Russell P ^s   Budoff, Matthew ^j   Watson, Courtney ^t   Armah, Kaku A ^b   Doebler, Donna ^b   Bryant, Kendall ^m   Justice, Amy C ^c,d   more..

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^f UNIVERSITY OF WASHINGTON   (United States)

^g UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^j HARBOR UCLA MEDICAL CENTER   (United States)

^k UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^l Baltimore HealthCare Access   (United States)

^m NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

ⁿ EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^o BAYLOR COLLEGE OF MEDICINE   (United States)

^p MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^q GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^r VETERANS AFFAIRS MEDICAL CENTER   (United States)

^s UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^t UNIVERSITY OF SOUTH CAROLINA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; COCAINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; VIRUS RNA;

ACUTE HEART INFARCTION; ADULT; AGE DISTRIBUTION; AGED; ALCOHOL CONSUMPTION; ARTICLE; CARDIOVASCULAR RISK; COMORBIDITY; FEMALE; FOLLOW UP; FRAMINGHAM RISK SCORE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENTAL FINDING; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SMOKING; SUBSTANCE ABUSE; VETERAN;

ADULT; AGED; COHORT STUDIES; COMORBIDITY; FEMALE; HEPATITIS C; HIV INFECTIONS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREVALENCE; RISK; SMOKING; VETERANS;

EID: 84875665977     PISSN: 21686106     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamainternmed.2013.3728     Document Type: Article

References (39)

1. Luther VP, Wilkin AM. HIV infection in older adults. Clin Geriatr Med. 2007;23(3): 567-583, vii.
2. Klein D, Hurley LB, Quesenberry CP Jr, Sidney S. Do protease inhibitors increase the risk for coronary heart disease in patients with HIV-1 infection? J Acquir Immune Defic Syndr. 2002;30(5):471-477.
3. Currier JS, Taylor A, Boyd F, et al. Coronary heart disease in HIV-infected individuals. J Acquir Immune Defic Syndr. 2003;33(4):506-512.
4. Triant VA, Lee H, Hadigan C, Grinspoon SK. Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. J Clin Endocrinol Metab. 2007;92(7):2506-2512.
5. Obel N, Thomsen HF, Kronborg G, et al. Ischemic heart disease in HIV-infected and HIV-uninfected individuals: A population-based cohort study. Clin Infect Dis. 2007;44(12):1625-1631.
6. DurandM, Sheehy O, Baril JG, Lelorier J, Tremblay CL. Association between HIV infection, antiretroviral therapy, and risk of acute myocardial infarction: A cohort and nested case-control study using Québec's public health insurance database. J Acquir Immune Defic Syndr. 2011;57(3):245-253.
7. Fultz SL, Skanderson M, Mole LA, et al. Development and verification of a "virtual" cohort using the National VA Health Information System. Med Care. 2006; 44(8)(suppl 2):S25-S30.
8. United States Department of Veteran Affairs. Ischemic Heart Disease (IHD)-Quality Enhancement Research Initiative. http://www.queri.research.va.gov/ ihd/default.cfm. Published 2011; updated March 12, 2012. Accessed January 22, 2013.
9. Every NR, Fihn SD, Sales AE, Keane A, Ritchie JR; QUERI IHD Executive Committee. Quality Enhancement Research Initiative in ischemic heart disease: A quality initiative from the Department of Veterans Affairs. Med Care. 2000;38(6) (suppl 1):I49-I59.
10. Maynard C, Lowy E, Rumsfeld J, et al. The prevalence and outcomes of inhospital acute myocardial infarction in the Department of Veterans Affairs Health System. Arch Intern Med. 2006;166(13):1410-1416.
11. Ives DG, Fitzpatrick AL, Bild DE, et al. Surveillance and ascertainment of cardiovascular events: The Cardiovascular Health Study. Ann Epidemiol. 1995;5(4): 278-285.
12. Butt AA, Fultz SL, Kwoh CK, Kelley D, Skanderson M, Justice AC. Risk of diabetes in HIV-infected veterans pre-and post-HAART and the role of HCV coinfection. Hepatology. 2004;40(1):115-119.
13. Chobanian AV, Bakris GL, Black HR, et al Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42(6):1206-1252.
14. McGinnis KA, Brandt CA, Skanderson M, et al. Validating smoking data from the Veterans Affairs Health Factors dataset, an electronic data source. Nicotine Tob Res. 2011;13(12):1233-1239.
15. Goulet JL, Fultz SL, McGinnis KA, Justice AC. Relative prevalence of comorbidities and treatment contraindications in HIV-monoinfected and HIV/HCV-coinfected veterans. AIDS. 2005;19(suppl 3):S99-S105.
16. Kraemer KL, McGinnis KA, Skanderson M, et al. Alcohol problems and health care services use in human immunodeficiency virus (HIV)-infected and HIVuninfected veterans. Med Care. 2006;44(8)(suppl 2):S44-S51.
17. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: Findings from the third National Health and Nutrition Examination Survey. JAMA. 2002;287(3):356-359.
18. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998; 97(18):1837-1847.
19. Powell TM, Bagnell ME. Your "survival" guide to using time-dependent covariates. SAS Global Forum 2012. http://support. sas. com/resources/papers/proceedings12/168-2012 .pdf. Published 2012. Accessed January 22, 2013.
20. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of competing risk. J Am Stat Assoc. 1999;94(446):496-509.
21. Freiberg MS, Chang CC, Skanderson M, et al Veterans Aging Cohort Study. The risk of incident coronary heart disease among veterans with and without HIV and hepatitis C. Circ Cardiovasc Qual Outcomes. 2011;4(4):425-432.
22. D'Agostino RB Sr, Grundy S, Sullivan LM,Wilson P; CHD Risk Prediction Group. Validation of the Framingham coronary heart disease prediction scores: Results of a multiple ethnic groups investigation. JAMA. 2001;286(2):180-187.
23. Friis-Møller N, Sabin CA, Weber R, et al Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group. Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med. 2003;349(21):1993-2003.
24. Friis-MøllerN, Reiss P, Sabin CA, et al;DADStudy Group. Class of antiretroviral drugs and the risk of myocardial infarction. N Engl J Med. 2007;356(17):1723-1735.
25. El-Sadr WM, Lundgren JD, Neaton JD, et al Strategies for Management of Antiretroviral Therapy (SMART) Study Group. CD4-count-guided interruption of antiretroviral treatment. N Engl J Med. 2006;355(22):2283-2296.
26. Sabin CA, Worm SW,Weber R, et al; D:A:D Study Group. Use of nucleoside reversetranscriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: A multicohort collaboration. Lancet. 2008; 371(9622):1417-1426.
27. Triant VA, Meigs JB, Grinspoon SK. Association of C-reactive protein and HIV infection with acute myocardial infarction. J Acquir Immune Defic Syndr. 2009; 51(3):268-273.
28. Lichtenstein KA, Armon C, Buchacz K, et al HIV Outpatient Study (HOPS) Investigators. Low CD4-T cell count is a risk factor for cardiovascular disease events in the HIV outpatient study. Clin Infect Dis. 2010;51(4):435-447.
29. Kuller LH, Tracy R, Belloso W, et al INSIGHT SMART Study Group. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med. 2008;5(10):e203. doi: 10.1371/journal.pmed.0050203.
30. Riddler SA, Smit E, Cole SR, et al. Impact of HIV infection and HAART on serum lipids in men. JAMA. 2003;289(22):2978-2982.
31. Baker JV, Duprez D, Rapkin J, et al. Untreated HIV infection and large and small artery elasticity. J Acquir Immune Defic Syndr. 2009;52(1):25-31.
32. Torriani FJ, Komarow L, Parker RA, et al; ACTG 5152s Study Team. Endothelial function in human immunodeficiency virus-infected antiretroviral-naive subjects before and after starting potent antiretroviral therapy: The ACTG (AIDS Clinical Trials Group) Study 5152s. J Am Coll Cardiol. 2008;52(7):569-576.
33. Hadigan C, Meigs JB, Corcoran C, et al. Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy. Clin Infect Dis. 2001;32(1):130-139.
34. Jacobson DL, Knox T, Spiegelman D, Skinner S, Gorbach S, Wanke C. Prevalence of, evolution of, and risk factors for fat atrophy and fat deposition in a cohort of HIV-infected men and women. Clin Infect Dis. 2005;40(12):1837-1845.
35. Grunfeld C, Saag M, Cofrancesco J Jr, et al Study of Fat Redistribution and Metabolic Change in HIV Infection (FRAM). Regional adipose tissue measured by MRI over 5 years in HIV-infected and control participants indicates persistence of HIVassociated lipoatrophy. AIDS. 2010;24(11):1717-1726.
36. Wohl D, Scherzer R, Heymsfield S, et al FRAM Study Investigators. The associations of regional adipose tissue with lipid and lipoprotein levels in HIVinfected men. J Acquir Immune Defic Syndr. 2008;48(1):44-52.
37. Friis-MøllerN, Thiébaut R, Reiss P, et al;DADstudy group. Predicting the risk of cardiovascular disease in HIV-infected patients: The Data Collection on Adverse Effects of Anti-HIV Drugs Study. Eur J Cardiovasc Prev Rehabil. 2010;17(5):491-501.
38. Law MG, Friis-Møller N, El-Sadr WM, et al; D:A:D Study Group. The use of the Framingham equation to predict myocardial infarctions in HIV-infected patients: Comparison with observed events in the D:A:D Study. HIV Med. 2006;7(4): 218-230.
39. Justice AC, Dombrowski E, Conigliaro J, et al. Veterans Aging Cohort Study (VACS): Overview and description. Med Care. 2006;44(8)(suppl 2):S13-S24.